COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts

Ken Shinmura, Maiko Nagai, Kayoko Tamaki, Masato Tani, Roberto Bolli

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Opioids confer biphasic (early and late) cardioprotection against myocardial infarction by opening mitochondrial ATP-sensitive K+ channels. It is unknown whether cyclooxygenase-2 (COX-2), which mediates ischemia-induced late preconditioning, also mediates opioidinduced cardioprotection. Isolated perfused rat hearts were subjected to 20 min of global ischemia followed by 20 min of reperfusion. BW-373U86 (BW), a δ-opioid receptor agonist, was administered 1, 12, or 24 h before death. Recovery of left ventricular developed pressure (LVDP) after ischemia-reper- fusion improved when BW was administered 1 or 24 h before ischemia (control: 57 ± 8, BW 1 h: 75 ± 5, BW 24 h: 85 ± 6%) but not when it was administered 12 h before (60 ± 5%). Levels of 6-keto-PGF1a (a stable metabolite of PGI2) in coronary effluent after 20 min of reperfusion were higher with 24-h BW pretreatment than in controls (1,053 ± 92 vs. 724 ± 81 pg/ml), whereas 6-keto-PGF1a levels at baseline did not differ. Administration of a selective COX-2 inhibitor, NS-398, abolished the late phase of cardioprotection (recovery of LVDP, 53 ± 8%) and attenuated the increase in PGI2 (706 ± 138 pg/ml) but did not block the early phase of cardioprotection. The selective COX-1 inhibitor SC-560 did not affect either phase of protection. Western immunoblotting revealed upregulation of PGI2 synthase protein 24 h after BW administration without changes in COX-1 and COX-2 protein levels. In conclusion, the late (but not the early) phase of δ-opioid receptor-induced preconditioning is mediated by COX-2. A functional coupling between COX-2 and upregulated PGI2 synthase appears to underlie this cardioprotective phenomenon in the rat.

Original languageEnglish
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume283
Issue number6 52-6
Publication statusPublished - 2002 Dec 1

Fingerprint

Epoprostenol
Cyclooxygenase 2
Opioid Analgesics
Ischemia
Reperfusion
Opioid Receptors
Ventricular Pressure
Cyclooxygenase 2 Inhibitors
Proteins
Up-Regulation
Western Blotting
Myocardial Infarction
prostacyclin synthetase

Keywords

  • Myocardial ischemia
  • Opioid
  • Prostaglandin
  • Reperfusion injury

ASJC Scopus subject areas

  • Physiology

Cite this

COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts. / Shinmura, Ken; Nagai, Maiko; Tamaki, Kayoko; Tani, Masato; Bolli, Roberto.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 283, No. 6 52-6, 01.12.2002.

Research output: Contribution to journalArticle

Shinmura, Ken ; Nagai, Maiko ; Tamaki, Kayoko ; Tani, Masato ; Bolli, Roberto. / COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts. In: American Journal of Physiology - Heart and Circulatory Physiology. 2002 ; Vol. 283, No. 6 52-6.
@article{7677d47bd1c34ab2a17ee098d1c8793e,
title = "COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts",
abstract = "Opioids confer biphasic (early and late) cardioprotection against myocardial infarction by opening mitochondrial ATP-sensitive K+ channels. It is unknown whether cyclooxygenase-2 (COX-2), which mediates ischemia-induced late preconditioning, also mediates opioidinduced cardioprotection. Isolated perfused rat hearts were subjected to 20 min of global ischemia followed by 20 min of reperfusion. BW-373U86 (BW), a δ-opioid receptor agonist, was administered 1, 12, or 24 h before death. Recovery of left ventricular developed pressure (LVDP) after ischemia-reper- fusion improved when BW was administered 1 or 24 h before ischemia (control: 57 ± 8, BW 1 h: 75 ± 5, BW 24 h: 85 ± 6{\%}) but not when it was administered 12 h before (60 ± 5{\%}). Levels of 6-keto-PGF1a (a stable metabolite of PGI2) in coronary effluent after 20 min of reperfusion were higher with 24-h BW pretreatment than in controls (1,053 ± 92 vs. 724 ± 81 pg/ml), whereas 6-keto-PGF1a levels at baseline did not differ. Administration of a selective COX-2 inhibitor, NS-398, abolished the late phase of cardioprotection (recovery of LVDP, 53 ± 8{\%}) and attenuated the increase in PGI2 (706 ± 138 pg/ml) but did not block the early phase of cardioprotection. The selective COX-1 inhibitor SC-560 did not affect either phase of protection. Western immunoblotting revealed upregulation of PGI2 synthase protein 24 h after BW administration without changes in COX-1 and COX-2 protein levels. In conclusion, the late (but not the early) phase of δ-opioid receptor-induced preconditioning is mediated by COX-2. A functional coupling between COX-2 and upregulated PGI2 synthase appears to underlie this cardioprotective phenomenon in the rat.",
keywords = "Myocardial ischemia, Opioid, Prostaglandin, Reperfusion injury",
author = "Ken Shinmura and Maiko Nagai and Kayoko Tamaki and Masato Tani and Roberto Bolli",
year = "2002",
month = "12",
day = "1",
language = "English",
volume = "283",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "6 52-6",

}

TY - JOUR

T1 - COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts

AU - Shinmura, Ken

AU - Nagai, Maiko

AU - Tamaki, Kayoko

AU - Tani, Masato

AU - Bolli, Roberto

PY - 2002/12/1

Y1 - 2002/12/1

N2 - Opioids confer biphasic (early and late) cardioprotection against myocardial infarction by opening mitochondrial ATP-sensitive K+ channels. It is unknown whether cyclooxygenase-2 (COX-2), which mediates ischemia-induced late preconditioning, also mediates opioidinduced cardioprotection. Isolated perfused rat hearts were subjected to 20 min of global ischemia followed by 20 min of reperfusion. BW-373U86 (BW), a δ-opioid receptor agonist, was administered 1, 12, or 24 h before death. Recovery of left ventricular developed pressure (LVDP) after ischemia-reper- fusion improved when BW was administered 1 or 24 h before ischemia (control: 57 ± 8, BW 1 h: 75 ± 5, BW 24 h: 85 ± 6%) but not when it was administered 12 h before (60 ± 5%). Levels of 6-keto-PGF1a (a stable metabolite of PGI2) in coronary effluent after 20 min of reperfusion were higher with 24-h BW pretreatment than in controls (1,053 ± 92 vs. 724 ± 81 pg/ml), whereas 6-keto-PGF1a levels at baseline did not differ. Administration of a selective COX-2 inhibitor, NS-398, abolished the late phase of cardioprotection (recovery of LVDP, 53 ± 8%) and attenuated the increase in PGI2 (706 ± 138 pg/ml) but did not block the early phase of cardioprotection. The selective COX-1 inhibitor SC-560 did not affect either phase of protection. Western immunoblotting revealed upregulation of PGI2 synthase protein 24 h after BW administration without changes in COX-1 and COX-2 protein levels. In conclusion, the late (but not the early) phase of δ-opioid receptor-induced preconditioning is mediated by COX-2. A functional coupling between COX-2 and upregulated PGI2 synthase appears to underlie this cardioprotective phenomenon in the rat.

AB - Opioids confer biphasic (early and late) cardioprotection against myocardial infarction by opening mitochondrial ATP-sensitive K+ channels. It is unknown whether cyclooxygenase-2 (COX-2), which mediates ischemia-induced late preconditioning, also mediates opioidinduced cardioprotection. Isolated perfused rat hearts were subjected to 20 min of global ischemia followed by 20 min of reperfusion. BW-373U86 (BW), a δ-opioid receptor agonist, was administered 1, 12, or 24 h before death. Recovery of left ventricular developed pressure (LVDP) after ischemia-reper- fusion improved when BW was administered 1 or 24 h before ischemia (control: 57 ± 8, BW 1 h: 75 ± 5, BW 24 h: 85 ± 6%) but not when it was administered 12 h before (60 ± 5%). Levels of 6-keto-PGF1a (a stable metabolite of PGI2) in coronary effluent after 20 min of reperfusion were higher with 24-h BW pretreatment than in controls (1,053 ± 92 vs. 724 ± 81 pg/ml), whereas 6-keto-PGF1a levels at baseline did not differ. Administration of a selective COX-2 inhibitor, NS-398, abolished the late phase of cardioprotection (recovery of LVDP, 53 ± 8%) and attenuated the increase in PGI2 (706 ± 138 pg/ml) but did not block the early phase of cardioprotection. The selective COX-1 inhibitor SC-560 did not affect either phase of protection. Western immunoblotting revealed upregulation of PGI2 synthase protein 24 h after BW administration without changes in COX-1 and COX-2 protein levels. In conclusion, the late (but not the early) phase of δ-opioid receptor-induced preconditioning is mediated by COX-2. A functional coupling between COX-2 and upregulated PGI2 synthase appears to underlie this cardioprotective phenomenon in the rat.

KW - Myocardial ischemia

KW - Opioid

KW - Prostaglandin

KW - Reperfusion injury

UR - http://www.scopus.com/inward/record.url?scp=0036889963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036889963&partnerID=8YFLogxK

M3 - Article

C2 - 12388283

AN - SCOPUS:0036889963

VL - 283

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 6 52-6

ER -